Montagu to auction bandage maker BSN Medical
BSN Medical has been put up for sale by Montagu Private Equity, its UK-based private equity owner, which expects to receive the planned €1.8 to €1.9 billion at auction.
Southern Cross CEO to leave
Southern Cross Healthcare Group plc said Thursday, September 4, that Chief Executive Bill Colvin is to leave the company as it announced another tranche of property sales.
Genethera Inc shelves bid for Oxford BioMedica
GeneThera Inc said Wednesday, September 3, that it has withdrawn its bid for Oxford Biomedica plc.
UPDATE: SkyePharma to set new terms for bonds ‘shortly’
The specialist drug delivery company SkyePharma plc is set to announce a renegotiation of its convertible bonds this week, according to a report by Reuters.
Oxford Biomedica shares down after chief executive leaves
Oxford BioMedica plc fell the most in 10 days in London trading following the resignation of CEO Mike McDonald after less than two months on the job.
GlaxoSmithKline, Valeant sign drug development deal
GlaxoSmithKline plc has signed a deal potentially worth up to US$820 million with Valeant Pharmaceuticals International to access the US drugmaker’s experimental epilepsy and pain treatments.